Date

Monday, 25 February 2013

Location

European Medicines Agency, Amsterdam, the Netherlands

This workshop focuses on aspects of paediatric clinical trials in type-2 diabetes mellitus (T2DM). Experts in the field, together with regulators and the pharmaceutical industry discuss suitable inclusion criteria, outcome measures and study designs in paediatric investigation plans in T2DM and approaches to enhance trial feasibility. Expressions of interest to be sent by 11/02/2013. Registration by invitation only.

Documents

Share this page